Tempest Therapeutics (TPST) EBT (QoQ) (2012 - 2025)
Tempest Therapeutics (TPST) EBT (QoQ) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.41 Bn | 131.56 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.14 Bn | 78.15 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.52 Bn | 60.34 Bn | 1.37 Bn |
| 4 | Moderna | 58.21 Bn | 53.07 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.95 Bn | 9.56 Bn | 668.28 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.30 Bn | 26.46 Bn | - |
| 10 | Tempest Therapeutics | 4.46 Mn | 3.66 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 71.67% |
| Sep 30, 2025 | -36.24% |
| Jun 30, 2025 | 4.80% |
| Mar 31, 2025 | 21.53% |
| Dec 31, 2024 | -29.97% |
| Sep 30, 2024 | -9.30% |
| Jun 30, 2024 | -19.32% |
| Mar 31, 2024 | -5.72% |
| Dec 31, 2023 | -13.30% |
| Sep 30, 2023 | 11.00% |
| Jun 30, 2023 | 1.34% |
| Mar 31, 2023 | 15.31% |
| Dec 31, 2022 | -3.53% |
| Sep 30, 2022 | 1.96% |
| Jun 30, 2022 | -4.27% |
| Mar 31, 2022 | -15.29% |
| Dec 31, 2021 | 9.62% |
| Sep 30, 2021 | -20.33% |
| Jun 30, 2021 | -31.80% |
| Mar 31, 2021 | 84.38% |